Published in Clin Exp Immunol on August 16, 2016
Update on Chlamydia trachomatis Vaccinology. Clin Vaccine Immunol (2017) 0.75
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65
Toll-like receptor control of the adaptive immune responses. Nat Immunol (2004) 19.15
Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol (2001) 18.80
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
Toll-like receptors in innate immunity. Int Immunol (2005) 12.24
Differential antigen processing by dendritic cell subsets in vivo. Science (2007) 8.42
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med (2000) 7.46
CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med (1999) 6.06
Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol (2004) 5.80
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A (1999) 5.66
Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 5.50
Vaccine adjuvants: putting innate immunity to work. Immunity (2010) 5.02
Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med (2002) 4.67
CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol (2006) 4.48
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med (2009) 4.27
Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med (2003) 3.41
Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol (2001) 3.39
Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol (2003) 3.39
Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol (2011) 3.32
Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol (2003) 3.17
Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol (1997) 2.89
New horizons in adjuvants for vaccine development. Trends Immunol (2008) 2.85
NK cell and DC interactions. Trends Immunol (2004) 2.68
CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity (2011) 2.50
Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe (2008) 2.40
Triggering TLR signaling in vaccination. Trends Immunol (2005) 2.09
Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med (1999) 2.05
Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J Exp Med (2002) 1.91
Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell (1995) 1.86
Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J Immunol (2004) 1.85
NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity (2012) 1.84
DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med (1998) 1.41
The path to a successful vaccine adjuvant--'the long and winding road'. Drug Discov Today (2009) 1.41
Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Invest (2011) 1.33
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood (2008) 1.32
The use of Toll-like receptor 7/8 agonists as vaccine adjuvants. Expert Rev Vaccines (2013) 1.26
Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists. Blood (2010) 1.24
Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. J Exp Med (2005) 1.21
Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev (2005) 1.18
Regulation of mouse NK cell development and function by cytokines. Front Immunol (2013) 1.14
Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun (2002) 1.12
Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection. Proc Natl Acad Sci U S A (2012) 1.08
TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. J Immunol (2005) 1.02
Toll-like receptors. II. Distribution and pathways involved in TLR signalling. Folia Biol (Praha) (2005) 0.99
Differences in interleukin-12 and -15 production by dendritic cells at the early stage of Listeria monocytogenes infection between BALB/c and C57 BL/6 mice. Cell Immunol (2000) 0.94
Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background. FEMS Immunol Med Microbiol (2007) 0.88
Decision criteria for resolving isotype switching conflicts by B cells. Eur J Immunol (2005) 0.88
Toll-like receptors, natural killer cells and innate immunity. Adv Exp Med Biol (2007) 0.81
Variable requirement of dendritic cells for recruitment of NK and T cells to different TLR agonists. J Immunol (2007) 0.80